Retour aux projets

12040.1;5 PFLS-LS

Method comparability as prerequisite for biomarker selection - feasibility study

Résumé

Method comparability as prerequisite for biomarker selection - feasibility study

Textes supplémentaires

Abstract

Together FHNW and ProteoMediX will translate verified research results to a clinically applicable diagnostic prototype test for the more accurate detection of prostate cancer addressing a clear unmet medical need. The final test will be based on a unique signature of protein analytes. This proposal comprises a feasibility study using an innovative biosensor-based approach to bridge the gap between mass spectrometrybased verification and immunoassay-based validation of promising diagnostic markers selected from a bundle of candidates, i.e. protein analytes. This feasibility study is key for entering full development aimed at bringing out ProteoMediX¿s first promising product with prognosticated peak sales of 20 million CHF per year.

Participants

Daniel Gygax

Kontaktperson

daniel.gygax@fhnw.ch

Fachhochschule Nordwestschweiz Daniel Gygax Gründenstrasse 40 Hochschule für Life Sciences 4132 Muttenz BL CH

Détails du projet

Office de recherche
INNOSUISSE
Statut du projet
Abgeschlossen
Type de projet
Forschungsprojekt
Date de début
2011-01-31
Date de fin
2012-09-16
Coûts totaux approuvés
CHF 92057.00
Section
20 Förderbereich Life Sciences
Domaine politique NABS
Nicht aufteilbare / nicht zuteilbare Forschung

Disciplines de recherche

  • T490 Biotechnology 100.0%